会计年度:2014-06-30收入分布
| 项目名称 | 主营业务收入 | 主营业务成本 | 主营业务毛利 | 毛利率 | ||||
| 房地产开发 | 37,907,448.21 | 27,774,703.13 | 10,132,745.08 | 26.73 | ||||
| 广告服务 | 2,540,633.32 | 838,673.00 | 1,701,960.32 | 66.99 | ||||
| 合计 | 1,116,633,800.55 | 915,515,876.88 | 201,117,923.67 | 18.01 | ||||
| 建安施工 | 891,779,043.18 | 845,126,436.14 | 46,652,607.04 | 5.23 | ||||
| 其他 | 12,226,327.26 | 1,509,369.03 | 10,716,958.23 | 87.65 | ||||
| 生物医药 | 161,107,486.68 | 31,795,894.98 | 129,311,591.70 | 80.26 | ||||
| 物业管理 | 11,072,861.90 | 8,470,800.60 | 2,602,061.30 | 23.50 | ||||
会计年度:2013-12-31
| 项目名称 | 主营业务收入 | 主营业务成本 | 主营业务毛利 | 毛利率 | ||||
| 房地产开发 | 301,213,886.98 | 187,018,538.48 | 114,195,348.50 | 37.91 | ||||
| 广告服务 | 5,113,207.39 | 1,746,684.50 | 3,366,522.89 | 65.84 | ||||
| 建安施工 | 2,820,453,016.01 | 2,745,571,592.63 | 74,881,423.38 | 2.65 | ||||
| 其他 | 44,845,323.69 | 21,014,260.13 | 23,831,063.56 | 53.14 | ||||
| 生物医药 | 379,694,829.24 | 60,044,371.68 | 319,650,457.56 | 84.19 | ||||
| 物业管理 | 21,430,394.70 | 19,034,373.99 | 2,396,020.71 | 11.18 | ||||
会计年度:2013-06-30
| 项目名称 | 主营业务收入 | 主营业务成本 | 主营业务毛利 | 毛利率 | ||||
| 房地产开发 | 65,556,368.00 | 33,942,624.00 | 31,613,744.00 | 48.22 | ||||
| 广告服务 | 2,981,314.00 | 621,530.00 | 2,359,784.00 | 79.15 | ||||
| 建安施工 | 1,095,927,394.00 | 1,042,932,516.00 | 52,994,878.00 | 4.84 | ||||
| 其他 | 26,295,419.00 | 16,139,995.00 | 10,155,424.00 | 38.62 | ||||
| 软件开发 | -- | -- | -- | -- | ||||
| 生物医药 | 176,994,771.00 | 30,065,635.00 | 146,929,136.00 | 83.01 | ||||
| 物业管理 | 8,199,472.00 | 9,028,889.00 | -829,417.00 | -10.12 | ||||
会计年度:2012-12-31
| 项目名称 | 主营业务收入 | 主营业务成本 | 主营业务毛利 | 毛利率 | ||||
| 抵消 | 252,404,912.00 | 247,222,909.00 | 5,182,002.00 | 2.05 | ||||
| 房地产开发 | 519,205,529.00 | 416,256,961.00 | 102,948,568.00 | 19.83 | ||||
| 广告服务 | 5,108,236.00 | 1,236,695.00 | 3,871,541.00 | 75.79 | ||||
| 合计 | 3,238,793,258.00 | 2,695,735,302.00 | 543,057,957.00 | 16.77 | ||||
| 建安施工 | 2,615,638,023.00 | 2,412,610,907.00 | 203,027,115.00 | 7.76 | ||||
| 其他 | 52,369,442.00 | 27,968,348.00 | 24,401,094.00 | 46.59 | ||||
| 软件开发 | 7,226,256.00 | 6,855,440.00 | 370,816.00 | 5.13 | ||||
| 生物医药 | 267,539,877.00 | 51,962,888.00 | 215,576,989.00 | 80.58 | ||||
| 物业管理 | 24,110,808.00 | 26,066,971.00 | -1,956,164.00 | -8.11 | ||||
会计年度:2012-06-30
| 项目名称 | 主营业务收入 | 主营业务成本 | 主营业务毛利 | 毛利率 | ||||
| 房地产开发及建安施工 | 1,165,034,467.00 | 1,004,484,431.00 | 160,550,036.00 | 13.78 | ||||
| 广告服务 | 2,486,500.00 | 465,534.00 | 2,020,966.00 | 81.28 | ||||
| 其他 | 27,631,272.00 | 13,743,011.00 | 13,888,260.00 | 50.26 | ||||
| 软件开发 | 5,450,777.00 | 6,100,204.00 | -649,427.00 | -11.91 | ||||
| 生物医药 | 131,884,933.00 | 23,131,999.00 | 108,752,934.00 | 82.46 | ||||
| 物业管理 | 11,646,883.00 | 14,062,190.00 | -2,415,307.00 | -20.74 | ||||
4/9 转到 
违法和不良信息举报电话：010-85650899 传真：010-85650844 邮箱：yhts@staff.hexun.com
Copyright©和讯网 北京和讯在线信息咨询服务有限公司 All Rights Reserved 版权所有 复制必究 京ICP备10021077号
Copyright©和讯网 北京和讯在线信息咨询服务有限公司 All Rights Reserved 版权所有 复制必究 京ICP备10021077号